U.S. Logistics Stock News

NYSE:ARMK
NYSE:ARMKHospitality

Is Aramark (ARMK) Still Undervalued Or Is Its Growth Story Already Priced In?

Aramark (ARMK) has drawn investor attention after recent share price moves, with the stock last closing at $53.76. The company’s performance and current valuation are in focus as investors reassess its long-term prospects. See our latest analysis for Aramark. Recent share price moves for Aramark sit against a longer run of strong momentum, with a 30 day share price return of 4.88% and a year to date share price return of 46.97%, alongside a 5 year total shareholder return of 114.02%. If...
NYSE:RF
NYSE:RFBanks

Regions Financial (RF) Gains Momentum, Is The Stock Still Undervalued?

Recent Performance Snapshot for Regions Financial Stock Regions Financial (RF) shares recently closed at $29.29, with recent returns of 1 day at 1.88%, past week at 1%, past month at 5.25%, and past 3 months at 13.70%. Over longer horizons, the stock shows a 6.28% year to date total return, 33.14% over the past year, 9.12x over 3 years, and 7.93x over 5 years. This provides investors with a view of how the bank’s shares have traded across different market periods. See our latest analysis for...
NasdaqGS:ILMN
NasdaqGS:ILMNLife Sciences

How Investors May Respond To Illumina (ILMN) Adding Eli Lilly R&D Chief To Its Board

Illumina, Inc. has expanded its Board of Directors from nine to ten members and appointed Daniel M. Skovronsky, M.D., Ph.D., Chief Scientific and Product Officer at Eli Lilly and President of Lilly Research Laboratories, as an independent director effective June 16, 2026. By adding a senior R&D leader with deep experience in drug discovery, clinical development, and precision medicine, Illumina is strengthening board-level expertise closely aligned with its genomics and multiomics...
NasdaqGS:STLD
NasdaqGS:STLDMetals and Mining

SQM Stock And 2 Global Exporters For Investors Looking Beyond Tech

Global markets are fixated on the sharp sell-off in technology and AI related stocks, with indices from the Nasdaq 100 to South Korea's Kospi under heavy pressure. While confidence in AI spending is being questioned and chipmakers react to shifting memory-chip demand, many investors are also looking at what sits outside the tech complex. This article focuses on a Global Non-Tech Exporters screener that filters for large, financially healthy companies in the US, UK, Canada, and Australia. You...
NYSE:PNFP
NYSE:PNFPBanks

Pinnacle Financial Partners (PNFP) Could Be 18% Undervalued As It Opens New Atlanta Headquarters

Pinnacle Financial Partners (PNFP) is drawing attention after announcing plans to establish its corporate headquarters at Ten Twenty Spring in Midtown Atlanta, consolidating leadership and housing about 400 team members across five floors. See our latest analysis for Pinnacle Financial Partners. The new headquarters decision comes after a mixed period for Pinnacle Financial Partners, with the share price at $96.03 and a recent 90 day share price return of 13.16%. This sits alongside a 3 year...
NYSE:CVI
NYSE:CVIOil and Gas

Is CVR Energy (CVI) Fairly Valued Following Its Refinery Improvement Narrative?

Recent price moves and what they mean for CVR Energy stock CVR Energy (CVI) has drawn attention after a stretch of weaker price performance, with the stock down about 16% over the past month and 17% over the past 3 months. See our latest analysis for CVR Energy. Looking beyond the recent pullback, CVR Energy’s share price has risen 7.98% year to date. The 1 year total shareholder return of 1.53% highlights that momentum has cooled after stronger multi year gains of 12.89% over 3 years and...
NYSE:CPNG
NYSE:CPNGMultiline Retail

Coupang (CPNG) Could Be 33% Below Fair Value Following CLSA Outperform Call

CLSA has initiated coverage of Coupang (CPNG) with an Outperform rating, highlighting the company’s first party focused e-commerce model and nationwide logistics network in South Korea as key drivers of its competitive edge. See our latest analysis for Coupang. Coupang’s recent share price action reflects mixed sentiment, with a 1 month share price return of 8.62% contrasting with a year to date decline of 25.07% and a 1 year total shareholder return that is down 39.52%. This suggests short...
NYSE:FCN
NYSE:FCNProfessional Services

Is FTI Consulting (FCN) Undervalued After New Risk And Energy Advisory Hires?

FTI Consulting (FCN) has drawn investor attention after appointing Jerome Nyssen as Senior Managing Director in its Risk Advisory practice, and adding Riccardo Siliprandi to lead a new energy advisory offering in Italy. See our latest analysis for FTI Consulting. Despite these senior hires in risk and energy advisory, FTI Consulting’s share price has softened, with the 90 day share price return down 14.78% and the 1 year total shareholder return down 11.58%, suggesting momentum has been...
NasdaqGM:BLZE
NasdaqGM:BLZEIT

How Backblaze’s Multi-Exabyte CoreWeave Deal At Backblaze (BLZE) Has Changed Its Investment Story

Backblaze, Inc. recently announced a multi-exabyte, US$335 million agreement to provide HDD-based storage capacity for CoreWeave, Inc.’s AI Object Storage, enabling more efficient tiering of data and preserving high-performance resources for intensive AI workloads across the model lifecycle. The deal deepens Backblaze’s role in AI infrastructure by plugging its cost-focused cloud storage into CoreWeave’s platform, where 9 of the top 10 AI model providers already run workloads, potentially...
NYSE:OII
NYSE:OIIEnergy Services

3 US Stocks With High ROE That Could Be Flying Under The Radar

Global growth signals are mixed, services activity in key regions is under pressure and bond markets are recalibrating rate expectations. In this kind of stop start backdrop, many investors keep circling the same large caps and wait for broker upgrades to move. The High-Quality Undiscovered Gems screener flips that script by focusing on smaller companies with solid fundamentals that are not yet crowded with institutional money. This article highlights 3 stocks from the screener that stand out...
NYSE:FICO
NYSE:FICOSoftware

Is FICO’s (FICO) Mortgage Rivalry and Youth Outreach Rewriting Its Core Risk Narrative?

Recently, Fair Isaac faced a major shift when US mortgage regulators approved rival VantageScore 4.0 for government-backed loans, while separately partnering with the Chelsea Foundation in the UK to promote youth financial literacy through soccer-linked events at Stamford Bridge. This mix of regulatory pressure on a core mortgage scoring franchise and long-term brand-building in financial education highlights how FICO’s business risks and social impact efforts are evolving at the same...
NasdaqGM:ENPH
NasdaqGM:ENPHSemiconductor

Enphase Energy (ENPH) Could Be 41% Below Fair Value Following Barclays Upgrade

Barclays recently upgraded Enphase Energy (ENPH), citing its emerging solid state transformer business for data centers and new IQ9S-3P Commercial Microinverter shipments in the U.S. as key product-driven catalysts. See our latest analysis for Enphase Energy. Those product launches and the Barclays upgrade come after a sharp pullback, with a 1-month share price return of down 26.25% and a 1-day drop of 9.90%, even though the year-to-date share price return is up 39.91% and the 1-year total...
NYSE:HUBB
NYSE:HUBBElectrical

Grid Infrastructure Momentum Could Be A Game Changer For Hubbell’s (HUBB) Electrification Narrative

In the first quarter of 2026, Hubbell reported robust organic growth, with particular strength in its Electrical Solutions and Grid Infrastructure businesses, underscoring its role in modernizing utility transmission, substations, and distribution networks. The company’s recent acquisitions and focused portfolio suggest an expanding footprint in grid controls and broader electrification infrastructure, positioning Hubbell as a key enabler of power reliability across multiple sectors. We’ll...
NasdaqGS:AXON
NasdaqGS:AXONAerospace & Defense

Axon’s Strong Results And Scottsdale Controversy Might Change The Case For Investing In Axon Enterprise (AXON)

In recent days, Axon Enterprise has reported strong Q1 2026 results, raised its full-year revenue outlook, expanded its AI-powered public safety platform, and simultaneously come under scrutiny for alleged political involvement in a contentious Scottsdale development and city council race. This combination of rapid product and contract momentum with rising concerns over corporate governance and local political influence creates a complex risk-reward profile for investors to evaluate. Now...
NYSE:HOMB
NYSE:HOMBBanks

Does Rising Institutional Support and Strong Fundamentals Change The Bull Case For Home BancShares (HOMB)?

In recent days, Home BancShares reported strong financial health, with year-over-year growth in both revenue and net profit and high industry rankings. At the same time, institutional ownership climbed and technical indicators strengthened, highlighting rising professional investor interest alongside robust operating efficiency. We will now examine how this improving institutional support might influence Home BancShares’ existing investment narrative and future positioning. We've uncovered...
NYSE:JOBY
NYSE:JOBYAirlines

The Bull Case For Joby Aviation (JOBY) Could Change Following Aggressive Pre-Certification Production Ramp-Up - Learn Why

Recently, Joby Aviation reported that it is close to securing full regulatory approval for its electric vertical takeoff and landing aircraft and has started ramping up production at facilities including Dayton, Ohio, aiming to support future commercial air taxi operations with partners such as Delta Air Lines. This shift from testing toward scaled manufacturing and service deployment marks a pivotal move toward revenue generation, but it also raises questions about how Joby will manage high...
NYSE:BHVN
NYSE:BHVNBiotechs

Biohaven (BHVN) Is Up 22.2% After Advancing Multiple Immunology And Oncology Candidates To Pivotal Trials

Earlier in June, Biohaven Ltd. reported that it was moving several key pipeline assets into the clinic, including new studies of BHV-1510 for advanced or metastatic epithelial tumors and BHV-1530 for urothelial cancer and other tumors. The company also outlined plans to start pivotal trials for BHV-1400 in IgA nephropathy and BHV-1300 for Graves’ disease, highlighting a broad push toward later-stage development across multiple immunology and oncology indications. We’ll now examine how...
NYSE:PFL
NYSE:PFLCapital Markets

Charles Schwab Stock and 2 Rate Sensitive Financials Under Pressure

Violent swings in US Treasury yields are rippling across markets, reshaping funding costs, bond valuations, and liquidity for companies that lean heavily on government debt markets. When borrowing costs jump and trading conditions turn choppy, some stocks can struggle with squeezed margins, pressured client activity, or balance sheets that are more exposed than they look at first glance. This article focuses on the risks, not the potential winners. It does this by breaking down 3 stocks from...
NasdaqGS:MORN
NasdaqGS:MORNCapital Markets

Is Morningstar (MORN) Quietly Redefining Its Moat With Accessible Private-Market Model Portfolios?

Morningstar, Inc. recently announced that its Morningstar Wealth division is working with Apollo Global Management, Franklin Resources, and J.P. Morgan Asset Management to create research-driven public/private model portfolios for financial advisors, while its board affirmed a quarterly dividend of US$0.50 per share payable on July 31, 2026. This collaboration aims to broaden access to private markets for individual investors by packaging private credit and real estate exposure into...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

How Viatris’ €650 Million Eurobond Issue (VTRS) Has Changed Its Investment Story

Earlier in June 2026, Viatris Inc. completed a €650 million offering of 4.250% fixed-rate senior unsecured Eurobonds due June 17, 2033, priced at 99.739% of face value with attached guarantees and callable features. This move adds a new layer to Viatris’ capital structure just as investors are focusing on its late-stage product pipeline, free cash flow above US$2.20 billion, and value-focused analyst ratings. We’ll now examine how Viatris’ fresh Eurobond issuance interacts with its...
NasdaqGS:CSCO
NasdaqGS:CSCOCommunications

Is Cisco Systems (CSCO) Fully Valued As AI And Quantum Network Deals Draw Interest?

Cisco Systems (CSCO) has moved into focus after Equinix expanded its work with Cisco and NVIDIA on the Secure AI Factory, alongside Cisco’s founding role in Rotterdam’s new Quantum Communication Fieldlab. See our latest analysis for Cisco Systems. Cisco Systems’ recent collaborations around the Secure AI Factory and quantum-secure networking come as the share price trades at US$121.15, with a 90-day share price return of 48.05% and a 1-year total shareholder return of 82.56%. This points to...
NasdaqGS:REG
NasdaqGS:REGRetail REITs

Earnings Miss And Cautious FFO Outlook Could Be A Game Changer For Regency Centers (REG)

Earlier this year, Regency Centers reported first-quarter funds from operations of US$1.20 per share, falling short of analyst expectations and pairing that with full-year FFO guidance of US$4.83 to US$4.87 per share that signaled management caution. This combination of an earnings miss and a restrained outlook has become a focal point for investors reassessing the resilience of its grocery-anchored retail portfolio. We’ll now examine how this first-quarter FFO shortfall and more cautious...
NYSE:KIM
NYSE:KIMRetail REITs

How Wolfe Upgrade and Debt Moves Will Impact Kimco Realty’s (KIM) Risk‑Reward Profile

On June 22, 2026, Wolfe Research upgraded Kimco Realty to Outperform, highlighting the REIT’s strong fundamentals and easing refinancing pressures following its recent US$525 million exchangeable notes offering. The upgrade underscores how Kimco’s focus on strengthening its balance sheet and funding growth initiatives is reshaping investor confidence in its retail real estate model. Now we’ll examine how reduced refinancing pressure and balance sheet moves influence Kimco’s existing...
NYSE:BRK.B
NYSE:BRK.BDiversified Financial

Berkshire Hathaway (BRK.B) Makes Its First Big Bets Under Greg Abel

Greg Abel, the new CEO of Berkshire Hathaway (NYSE:BRK.B), has led major portfolio changes, including new investments in Macy's, Delta Air Lines, and Alphabet. The company has also tripled its stake in the New York Times and agreed to acquire homebuilder Taylor Morrison. These moves come as Berkshire refines its equity portfolio and continues to use share buybacks to align with shareholders. Berkshire Hathaway operates as a diversified holding company with large insurance, energy,...